Retatrutide, a first-in-class, once-weekly triple hormone RA, has a mechanism of action that activates the body's GIP, GLP-1, and glucagon receptors
GLP-1 Patches
While FDA labeling includes no specific contraindication for inflammatory bowel disease, the medication's gastrointestinal side effectsincluding nausea, diarrhea, and abdominal painoverlap significantly with ulcerative colitis symptoms
When to Reach Out: Know Your Body's Signals Mild to moderate nausea is expected and usually resolves within the first month
Yes, Mounjaro can cause hives, skin rashes, and injection site reactions, although these are usually mild
Depending on your dose, comfort, and cost factors, other options are also available